Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
5.04
0.00 (0.00%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $276.05 million as of October 2, 2026. Its market cap has decreased by -72.51% in one year.
Market Cap
276.05M
Enterprise Value
15.69M
1-Year Change
-72.51%
Ranking
Category
Stock Price
$5.04
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has decreased from $393.35M to $276.05M, a decrease of -29.82%. That is a compound annual growth rate of -16.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 276.05M | -81.18% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 283.89M |
| Fulcrum Therapeutics | 281.54M |
| Rocket Pharmaceuticals | 281.02M |
| X4 Pharmaceuticals | 280.59M |
| EyePoint | 280.19M |
| Vanda Pharmaceuticals | 279.94M |
| Fate Therapeutics | 277.98M |
| Century Therapeutics | 277.05M |